Radiosurgery for pituitary metastases.

Neurol Med Chir (Tokyo)

Department of Neurosurgery, Osaka City General Hospital, Osaka, Japan.

Published: March 2004

Gamma knife radiosurgery (GKS) was used to treat seven patients with pituitary metastases between November 1994 and February 2003. The diagnoses were based on magnetic resonance imaging and clinical symptoms in six patients and by previous surgery in one patient. The cancer originated in the lung in five patients, and in the breast in two patients. The tumor volume was 0.2 to 9.6 cm3 (mean 4.0 cm3). The marginal dose was 10 to 14 Gy (mean 11.9 Gy) because of the close proximity to the optic apparatus. The maximum radiation dose to the optic apparatus was 8 to 10 Gy (mean 9.5 Gy). The survival period after GKS was 0.3 to 42 months (mean 11.5 months). Five patients died of systemic disease, and one patient died of unknown causes 10 days after GKS. Tumor growth was controlled in five of the six patients (83%) followed up after GKS. Tumor regrowth was seen 18 months after GKS in one patient. The clinical symptoms improved in five of the six patients (83%) followed up. GKS is effective and useful for the primary treatment of pituitary metastases with limited survival and less invasiveness compared to conventional radiation therapy.

Download full-text PDF

Source
http://dx.doi.org/10.2176/nmc.44.112DOI Listing

Publication Analysis

Top Keywords

pituitary metastases
12
clinical symptoms
8
optic apparatus
8
gks tumor
8
patients 83%
8
83% gks
8
patients
7
gks
6
radiosurgery pituitary
4
metastases gamma
4

Similar Publications

Background: Maximal safe resection is the objective of most neuro-oncological operations. Intraoperative magnetic resonance imaging (iMRI) may guide the surgeon to improve the extent of safe resection. There is limited evidence comparing the impact of iMRI on the rates of further resection between tumour types.

View Article and Find Full Text PDF

Metastases to the pituitary gland are a rare finding, with breast and lung being the most common metastases in this anatomical region. Pituitary melanoma metastases reports are thus sparse, and both diagnosis and treatment are challenging. We present the case of a 66-year-old woman with pituitary melanoma metastasis who presented with symptoms of anterior pituitary dysfunction and headache.

View Article and Find Full Text PDF

Background: One avenue to improve outcomes among brain tumor patients involves the mitigation of healthcare disparities. Investigating clinical differences among brain tumors across socioeconomic and demographic strata, such can aid in healthcare disparity identification and, by extension, outcome improvement.

Methods: Utilizing a racially diverse population from Hawaii, 323 cases of brain tumors (meningiomas, gliomas, schwannomas, pituitary adenomas, and metastases) were matched by age, sex, and race to 651 controls to investigate the associations between tumor type and various demographic, socioeconomic, and medical comorbidities.

View Article and Find Full Text PDF

Clinical confocal laser endomicroscopy for imaging of autofluorescence signals of human brain tumors and non-tumor brain.

J Cancer Res Clin Oncol

December 2024

Department of Neurosurgery, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Purpose: Analysis of autofluorescence holds promise for brain tumor delineation and diagnosis. Therefore, we investigated the potential of a commercial confocal laser scanning endomicroscopy (CLE) system for clinical imaging of brain tumors.

Methods: A clinical CLE system with fiber probe and 488 nm laser excitation was used to acquire images of tissue autofluorescence.

View Article and Find Full Text PDF
Article Synopsis
  • - Acromegaly is a rare condition caused by excessive growth hormone secretion, typically from a pituitary adenoma, leading to high levels of insulin-like growth factor 1 and various severe health issues.
  • - Pituitary adenomas (PAs) show a wide range of clinical and biological characteristics and can behave aggressively, making them challenging to classify and treat effectively over time.
  • - The latest WHO Classification categorizes GH-secreting PAs into different types based on hormonal features, but more research is needed to better understand their behavior and improve treatment strategies through precision medicine.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!